Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1057 - 1064 of 12107 results

Side Letter: CalPERS' Co-invest Conviction
March 12, 2024| News

New Mexico’s Health Care Consolidation Oversight Act: An Overview
March 11, 2024| Blog| Viewpoint

Northeastern Law Magazine Profiles Member Drew DeVoogd
March 9, 2024| News

How IP Lawyers Are Meeting Clients’ Patent Licensing Needs
March 8, 2024| News

Health Law Diagnosed – A Discussion on the Regulatory Requirements for LDTs
March 7, 2024| Podcast| Viewpoint

DOJ and FTC Weigh in on Alleged Algorithmic Price Fixing — AI: The Washington Report
March 7, 2024| Article| Viewpoint

How Can the Updated USPTO Guidance on Determining Obviousness Help You?
March 7, 2024| Blog| Viewpoint

FDA Faces Critical Deadlines in 2024, Even Without an Election Looming
March 6, 2024| Blog| Viewpoint
News & Press Releases
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
